Cas:112894-37-8 (2R)-2-[(1S)-1,2-dihydroxyethyl]-4-ethoxy-3-hydroxy-2H-furan-5-one manufacturer & supplier

We serve Chemical Name:(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-ethoxy-3-hydroxy-2H-furan-5-one CAS:112894-37-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-ethoxy-3-hydroxy-2H-furan-5-one

Chemical Name:(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-ethoxy-3-hydroxy-2H-furan-5-one
CAS.NO:112894-37-8
Synonyms:801M14RK9K;L-2-ethyl-ascorbic acid;L-ascorbic acid ethyl ester;L-Ascorbic acid,2-O-Ethyl;2-O-Ethyl ascorbic acid;UNII-801M14RK9K;EVC-2;(R)-5-((S)-1,2-Dihydroxyethyl)-3-ethoxy-4-hydroxyfuran-2(5H)-one;2-O-ethyl-L-ascorbic acid
Molecular Formula:C8H12O6
Molecular Weight:204.17700
HS Code:2932209090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:506ºC at 760mmHg
Density:1.46g/cm3
Index of Refraction:1.555
PSA:96.22000
Exact Mass:204.06300
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 801M14RK9K chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-O-ethyl-L-ascorbic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,801M14RK9K Use and application,801M14RK9K technical grade,usp/ep/jp grade.


Related News: In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. (2,6-dimethylphenyl)methoxymethyl-phenylsilane manufacturers The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture. (2,6-dimethylphenyl)methoxymethyl-(2-methylphenyl)silicon suppliers Building on this progress, recombinant technologies have been key to optimizing the performance of biocatalytic reagents, for example by facilitating a reduction in the amount of enzyme needed to drive a reaction while at the same time increasing the yield. 2,2-bis(2,6-dimethylphenyl)ethoxymethylsilane vendor & factory.